The novel approach of tirzepatide peptide represents a exciting advance in the management of diabetes mellitus type 2. Different to existing drugs, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatide-peptide185727.timeblog.net/77924822/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment